| (+)-Menthofuran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (±)-N-3-Benzylnirvanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| (-)-(E)-Guggulsterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.19% |
| (-)-Fenchone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| (-)-Vorozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (2E,6E,10E)-12-Hydroxyfarnesol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (3S,5S)-Atorvastatin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| (E/Z)-DMU2105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (E/Z)-DMU2139 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (E/Z)-Piperine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.91% |
| (R)-(+)-Aminoglutethimide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.08% |
| (R)-(+)-Aminoglutethimide L-Tartrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-4-Benzyl-2-oxazolidinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| (R)-6',7'-Dihydroxybergamottin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-CYP3cide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| (R)-Mephenytoin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| (R)-N-3-Benzylnirvanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Talarozole (R enantiomer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.7% |
| (R)-Esomeprazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.41% |
| (R)-Reticuline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R,R)-Voriconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Ketoconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Vorozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-δ-Viniferin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Brassinazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-(+)-N-3-Benzylnirvanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| (S)-Aminoglutethimide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-Desmethylcitalopram |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-Dexfadrostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-Mephenytoin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| (S)-Pulegone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Z)-Norendoxifen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (±)-ε-Viniferin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (±)13(14)-EpDPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (±)14,15-Epoxyeicosatrienoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| (±)5(6)-EET Ethanolamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,2,3,4,7,8,9-Heptachlorodibenzofuran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,2,3,4,7,8-Hexachlorodibenzofuran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,2,3,6,7,8-Hexachlorodibenzofuran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,2-Dimethylnaphthalene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,4-Dihydroxy-2-naphthoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| 1,4-Dihydroxy-2-naphthoic acid (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |
| 2-Phenyl-2-(1-piperidinyl)propane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| 1-(Isothiazol-3-yl)ethan-1-one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.26% |
| 1-Tritylimidazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| 1-Ethynylpyrene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.10% |
| 1-Ethynylnaphthalene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.27% |
| 1-Aminobenzotriazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| 1-Hydroxypyrene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| 1-Hydroxypyrene-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| 10-Hydroxywarfarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 11,12-DiHETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 11-HETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 11-Ketoprogesterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| 14(15)-EpETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 16(S)-HETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 16-Dehydropregnenolone acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 16a-Hydroxydehydroisoandrosterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| 16α-Hydroxy etiocholanolone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 17(R)-HETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 17(S)-HETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 17-HETE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 17-ODYA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Clobetasol 17-Propionate-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1β-Hydroxydeoxycholic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| Phloracetophenone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| 2,3,4,6,7,8-Hexachlorodibenzofuran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2,6-Dimethylquinoline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.19% |
| 2,7-Dimethylnaphthalene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| 2-(3-Pyridyl)-benzimidazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MCPA-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2-(Isopentylamino)naphthalene-1,4-dione |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2-Hydroxybenzimidazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| 2-Hydroxybenzimidazole (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |
| 2-Me PeER |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2-Pentylbenzimidazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 20-HEDE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.11% |
| 20-HETE IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 20-HETE inhibitor-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 20-HETE inhibitor-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.16% |
| 20-Hydroxyvitamin D3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 20-SOLA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| 20α-Dihydroprogesterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.07% |
| 21-Hydroxypregnenolone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| 22-HDHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3'-Methoxy-4'-nitroflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3,4-Methylenedioxyphenmetrazine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3-Hydroxyflunitrazepam |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3-Methoxyphenylethylamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.39% |
| 3-Methylbenzofuran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3-Methylquinoline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| 3-Phenylthiophene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3-Cyano-7-ethoxycoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.40% |
| 4'-Methylchrysoeriol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.17% |
| 4,5-Dimethoxycanthin-6-one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.68% |
| 4-(Trifluoromethyl)umbelliferone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| 4-Hydroxyretinoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94.58% |
| 4-Ipomeanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Phenyl-1,2,3-thiadiazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| 4-Pyridylmethyl adamantanecarboxamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| 4-Chlorophenylacetic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| 5,7,2',6'-Tetrahydroxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,7-Dimethoxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| 5-Methyl-7-methoxyisoflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.13% |
| 5-Methylchrysene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5-Hydroxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| 5α-Androst-2-en-17-one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5-trans-PGE2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6',7'-Dihydroxybergamottin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| 6',7'-Epoxybergamottin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6-Hydroxywarfarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| 6-Ketocholestanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.68% |
| 6-Methylchrysene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| 6β-Hydroxy androstenedione |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7-Benzyloxy-4-(trifluoromethyl)coumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| 7-Ethoxy-4-methylcoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| 7-Ethoxycoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| 7-Ethoxycoumarin-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7-Hydroxyflavanone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| 7-Methoxy-4-(trifluoromethyl)coumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| 7-Methoxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| 7-Methylcoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| Chloroxoquinoline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7ETMC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7H-Dibenzo[c,g]carbazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| 7α-Hydroxy-DHEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| β-Apo-8'-carotenal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.57% |
| 8-Geranyloxypsoralen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| 8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Abiraterone decanoate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| Abiraterone decanoate-d17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ACC2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acid Yellow 36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70.0% |
| ACP-5862 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.32% |
| ACP-5862-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADDA 5 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.16% |
| Adenosine receptor antagonist 6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADL-5859 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| ADL5859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AHR agonist 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aldoview |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ALT-2074 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AMG-208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Androsta-1,4,6-triene-3,17-dione |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| Anthraflavic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Antibacterial agent 102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antibacterial agent 132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 310 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 318 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antifungal agent 114 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antifungal agent 122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antifungal agent 136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.15% |
| Antifungal agent 137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antihistamine-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| Antimycin A2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Antioxidant agent-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antiproliferative agent-53-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-183 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-87 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antiviral agent 81 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| APD668 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| Apigenin-13C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Apigenin-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Apoptosis inducer 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AR-C141990 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Arasertaconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aripiprazole impurity 38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aromatase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aromatase-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aromatase-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aromatase-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aromatase-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aromatase-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AS1810722 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| Aschantin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASN-001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aspergillusidone D |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aspergillusidone F |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avatrombopag maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| AZ-11665362 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Azalanstat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Azamulin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.94% |
| AZD7325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| BChE-IN-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BDE33872639 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Becliconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benoxaprofen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| Benoxaprofen-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benzobarbital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benzylmethyl ether |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.70% |
| Benzylurea |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Bergamottin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| BI 653048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| BI 653048 phosphate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI 689648 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.20% |
| BMS-223131 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-344577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-351 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-570520 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-764459 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-819881 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| BMS-986202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| BMS-986339 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| BNS808 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Butylcyclohexane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BVT948 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| C5F2-HCB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX/VEGFR-2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Carvedilol metabolite 4-Hydroxyphenyl Carvedilol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.42% |
| Casopitant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Casopitant mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| Caspase-3/7 activator 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CAY 10434 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CAY 10462 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| CD564 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDD3505 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| CDD3506 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| Cecropin B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| Cedrol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Cephaeline dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| Cetagliptin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CGP 47645 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CGP-45688 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CGS 18320B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chalepensin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.98% |
| CHL2310 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlormethiazole hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Cholesterol 24-hydroxylase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| Cholesterol 24-hydroxylase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cholesterol 24-hydroxylase-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.74% |
| Cilobamine methanesulfonate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cimicoxib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Clobetasol propionate-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cloperidone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cloperidone hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cloranolol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Columbamine chloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.62% |
| COX-2/Aromatase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| COX-2/Aromatase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CP-506 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CP-506 mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.59% |
| Curcumenol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| CYP11A1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.90% |
| CYP11A1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP11A1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP11B1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP11B1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP11B2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| CYP11B2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP11B2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP121A1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP17-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP17A1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP17A1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP17A1/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP19A1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP19A1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| CYP19A1/CYP11B2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| CYP1A1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1A1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1 ligand 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| CYP1B1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-14 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.09% |
| CYP1B1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| CYP1B1-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| CYP1B1-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP1B1-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP2A6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP2A6-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP2C1/CYP2C19-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP2C19-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP2C9/CYP2C19-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP2E1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| CYP3A4 enzyme-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP3A4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP3A4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP3A4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP3A4-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP3A4-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP3cide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| CYP450-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP4A11/CYP4F2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| CYP4A11/CYP4F2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP4Z1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP4Z1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP4Z1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-23-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/Hsp90-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/PD-L1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/PD-L1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/PD-L1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/PD-L1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cyprocide-B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cytochrome c-pigeon (88-104) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DA-0157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| Dafadine-A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| Dagrocorat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Dagrocorat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Dapaconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Dasatinib analog-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.08% |
| DD202-114 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.27% |
| DDMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.19% |
| Debutyldronedarone-d6 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.27% |
| Debutyldronedarone-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dehydro-ZINC39395747 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| Denzimol hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Desfluoro-BMS-694153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Desmethyl Bosentan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Desmethylcitalopram hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Desmethylcitalopram-d4 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dexfadrostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.75% |
| Dexfadrostat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dibenzylfluorescein |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| Dicobalt edetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Dihydrocubebin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dihydrolanosterol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| Dihydrolanosterol-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Dimethocaine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| Diosmetin-3-O-glucuronide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DL-Acetylshikonin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DLCI-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DMU2105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| DMU2139 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| DNA Gyrase/ribosomes-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNDI-6510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNDI-VL-2098 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNP-INT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Doxylamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| Doxylamine-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| DP-b99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| DPC-681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.80% |
| Dronedarone-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| E-2101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| E-5110 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Echihumiline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Edelfosine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| EDP-305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.02% |
| EGFR-IN-137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EGFR/DHFR-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ELQ-453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EMT inhibitor-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.83% |
| EMT inhibitor-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Endoxifen-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Endoxifen-d5 (Z-isomer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EP102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eriodictyol chalcone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.25% |
| Erysolin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| ERα degrader 6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ERα degrader 9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Escholtzine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Escholtzine perchlorate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ETX1975-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ezutromid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.87% |
| F44-A13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.73% |
| Fadrozole hydrochloride hemihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| Fandosentan potassium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fenaminstrobin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fenofibrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Feruloylputrescine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| FGFR-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FGFR2/3-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FGFRs-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Filapixant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| FLT3-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| Flu-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| Fluxapyroxad |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| FPH1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| FR 901537 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Frutinone A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.78% |
| FUB 349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| G256 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| G256 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Galeterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Galeterone hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ganolucidic acid B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemfibrozil 1-O-β-glucuronide-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemfibrozil-d6-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GlcN-6-P Synthase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Glucoarabin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Glucoraphasatin potassium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Glucoraphenin potassium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| GNF7686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK2945 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK2945 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.49% |
| GSK3β-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GW 610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| GW273297X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GW694481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GW844520 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GYKI-47261 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GYKI-47261 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H-D-Tpi-OH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HBV-IN-57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| hCYP1B1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| hCYP1B1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| hCYP3A4 Fluorogenic substrate 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| hCYP3A4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Herbicide safener-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Herbicide safener-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HET0016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| Hexamethylphosphoramide-d18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HIV-1 inhibitor-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HIV-1 inhibitor-58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HIV-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HN0037 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| Hydroaurantiogliocladin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IDO1-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.82% |
| IDO1-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IHMT-PI3Kδ-372 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| IMP-Zn |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Inz-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ipriflavone metabolites IV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IR-783 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| Isobavachin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Isoglycycoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isolimonexic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isopsoralidin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| K777 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| K777 tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KBP-7018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KBP-7018 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Keto-itraconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.4% |
| KOSN 1724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lapiteronel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.51% |
| LEQ803 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| LEQ803-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Levinoid C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Levoketoconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.39% |
| Liarozole dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.04% |
| Liarozole fumarate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Liarozole hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Linderane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.61% |
| LKY-047 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Lorundrostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| LP8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LS2265 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lunacalcipol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LY113174 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LY43578 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| LY56110 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MCH-1 antagonist 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MCPA sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MCPA-13C8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MCPA-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.30% |
| MDL-811 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Mefentrifluconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| MeIQx |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| MeIQx-13C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Melperone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Melperone (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Melperone hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Melperone-d4 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Mephenytoin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Mephenytoin-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mephenytoin-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Mephenytoin-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.72% |
| Mephenytoin-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| meso-Zeaxanthin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93.09% |
| Methoxsalen-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Metyrapone Tartrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MI-883 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| MI1013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| MI891 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minamestane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mitiperstat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.12% |
| Mitiperstat-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MK-3901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MK-5596 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ML252 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| ML252 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MLS peptide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Monoamine oxidase/Aromatase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Monoethyl phthalate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.58% |
| Monoethyl phthalate-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.27% |
| Mosapride citrate dihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| Moth Cytochrome C (MCC) (88-103) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS-PPOH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| Mtb-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MTTC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Multiflorin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Musk ketone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| Myrothecine A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Desmethyl diltiazem hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90.0% |
| N-Desmethyl Eletriptan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Desmethyl Rilmazolam |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Desmethyl rosiglitazone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Desmethyl-Apalutamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| N-Desmethyl-Apalutamide-15N,d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Formyldemecolcine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Nornuciferine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| N-Nornuciferine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nampt-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Naringin hydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nav1.7-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neoquassin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Nicotelline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.88% |
| Nivasorexant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| NN1177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| NN1177 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| NNC 55-0396 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.43% |
| NNC 55-0396 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NNRT-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NP10679 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| NSC 23925B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NT-0527 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Obtusifoliol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Octachlorodibenzo-p-dioxin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octahydrocoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octinoxate-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octocrylene-13C3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ODM-204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ONT-993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Opelconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.41% |
| Opevesostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Org30958 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Orphenadrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| Orteronel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Oteseconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Oxiconazole nitrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| P-gp inhibitor 23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Panaxytriol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paramethasone Acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Paroxetine acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| PELI1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Pentacosafluorotridecanoic Acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| Pentacosafluorotridecanoic Acid (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Perafensine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PeS-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phenyltoloxamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phillyrin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.82% |
| Phortress |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.19% |
| Phortress free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pipercroside A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pipercroside B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Piperonylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Polθ-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Potassium 1H-indol-3-yl sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| PPOH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Pregnenolone 16α-carbonitrile |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.42% |
| Proadifen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proadifen-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC CYP1B1 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.09% |
| PROTAC CYP1B1 degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC ERα Degrader-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prothioconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Prothioconazole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prothipendyl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prothipendyl hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Pseudotaraxasterol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.01% |
| PSMA-Val-Cit-PAB-MMAE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| PY109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.15% |
| PZ-1657 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quecitinib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| Quercetin 3-gentiobioside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| Quilseconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.61% |
| Quinidine N-oxide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| R-116010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RB-90740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RET-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revexepride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| RG-12525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.31% |
| RO6889678 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rogletimide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rotenolone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| RPR203494 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rutaevin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| S-(N-PhenethylthiocarbaMoyl)-L-cysteine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Saccharolactone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sapindoside B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.68% |
| SCYX-6759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SDZ-285604 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SDZ285428 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| Senkirkin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.79% |
| Seviteronel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| Seviteronel (R enantiomer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.82% |
| Seviteronel racemate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| Simmitecan hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SJPYT-310 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| SJPYT-328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SKF 104976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SNT-5382 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Solavetivone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SOS1-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Soticlestat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| SR9186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| SS-750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SU 10603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| SU-8000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sudan IV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Sudan IV (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.24% |
| Sulcatone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| Sulcatone-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SYN20028567 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tabimorelin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| Tabimorelin hemifumarate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tan-931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TBPH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| TCF4/β-catenin-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TDI-015051 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tebuconazole-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Terretonin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tesmilifene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tesmilifene hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tesmilifene-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Testololactone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TGFBR1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thaspine acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thermopsoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Thienyldecyl Isothiocyanate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thujopsene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ticlopidine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Ticlopidine hydrochloride-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ticlopidine-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tienilic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| TMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| Tolterodine tartrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.64% |
| Topo I/II-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TP0472993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.22% |
| TRPV1 antagonist 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| TS-011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| TUPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Uniconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.98% |
| Uniconazole-P |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| URAT1-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Urotensin-II receptor antagonist-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Utreloxastat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.32% |
| Verapamil-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Veratrole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| Veratrole-d10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Veratrole-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.7% |
| Veratrole-d2-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Veratrole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Veratrole-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.7% |
| Versicolorin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vildagliptin carboxylic acid metabolite TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VNI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vorozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VT-1598 tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VU6001966 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| VU6008677 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Xanthine oxidoreductase-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| YM116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YM511 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| ZINC05626394 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.8% |
| ZSTK3744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZSTK3744 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZY12201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| α-Glucosidase-IN-101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| α-Terpinyl acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93.88% |
| α-Pinene oxide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.75% |
| Alpha-Naphthoflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| β-Cedrene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| β-Amyrenonol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| γ-Dodecanolactone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gamma-heptalactone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| δ-Viniferin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ε-Viniferin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.15% |
| Pretilachlor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.25% |
| Clobetasol propionate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Tongkat Ali Extract |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Danshenxinkun A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Rhapontigenin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Rhapontigenin 3'-O-glucoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Salvianolic acid C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| Ethylvanillin-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ethylvanillin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| 7-Ethoxyresorufin-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.89% |
| 7-Ethoxyresorufin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| Acetylshikonin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Abiraterone acetate-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dipropyl disulfide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| N,N-Diethylacetamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dihydrokavain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| MCPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.17% |
| Dibenzothiophene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Dibenzothiophene-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schisandrin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Schisandrol B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Human CYP1A2,Low-Reductase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Human CYP4A11,Low-Reductase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0% |
| Human CYP4A11,High-Reductase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ginsenoside C-K |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Ginsenoside C-K (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97% |
| Ginsenoside F1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Ginsenoside Rd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Ginsenoside Rd (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Talarozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Mancozeb |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85.50% |
| Itraconazole-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| Itraconazole-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.62% |
| Itraconazole-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.86% |
| Itraconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| Bergapten-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bergapten |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Ipriflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Exemestane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Exemestane-13C3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exemestane-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exemestane-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exemestane (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.01% |
| Exemestane-13C,d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exemestane-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clarithromycin (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Clarithromycin-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Clarithromycin-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Clarithromycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Hexachloroethane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hexamethylphosphoramide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Dronedarone-d6 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dronedarone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Liarozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| Peucedanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Seneciphylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Cepharanthine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Flavokawain A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| Co(III) protoporphyrin IX chloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95% |
| Desmethoxyyangonin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.00% |
| Desoximetasone-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bifeprofen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dihydrosesamin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diacetazotol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90.0% |
| Cobicistat-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cobicistat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.49% |
| Gemfibrozil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Gemfibrozil-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemfibrozil (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| Gemfibrozil 1-O-β-glucuronide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Furafylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| Cyprodinil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.84% |
| Cyprodinil-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cyprodinil-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tetrahydrocurcumin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| Tetrahydrocurcumin-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tetrahydropiperine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| Endoxifen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Endoxifen hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| Desoximetasone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| Diosmetin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| Diosmetin (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Rehmannioside A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| (R)-Omeprazole sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| 7-Epi-docetaxel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.76% |
| Nefazodone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.01% |
| Quinidine (15% dihydroquinidine) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.36% |
| Quinidine polygalacturonate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quinidine gluconic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octocrylene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.68% |
| Oxiconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Oxolamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Omeprazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Omeprazole sulfone (methoxy-d3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Omeprazole-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Omeprazole sulfone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.23% |
| Omeprazole sulfone-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Omeprazole sulfone-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Omeprazole sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| Omeprazole-d3 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Omeprazole magnesium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Omeprazole-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| Omeprazole-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.99% |
| Omeprazole-d3-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.09% |
| Levomepromazine maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Bucolome |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.93% |
| Pradefovir |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paramethasone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paroxetine (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Paroxetine-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paroxetine-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paroxetine-d6-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paroxetine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Isosilybin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Roquefortine C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.42% |
| Roquefortine C-13C22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isoasatone A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Oxadiazon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.51% |
| Tebuconazole-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tebuconazole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tebuconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| Topiroxostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| Topiroxostat-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tolterodine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.61% |
| Tolterodine-d14 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Stiripentol-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stiripentol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Flavanone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| 4-Nitro-3-(trifluoromethyl)phenol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Letrozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Letrozole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.23% |
| Naringin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Limonin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| Oxolamine citrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Oleuropein |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Olivetol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Olivetol-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Picolinafen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fipronil-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |
| Fipronil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.49% |
| Quinine hydrobromide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aminoglutethimide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.87% |
| Chlorpromazine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Chlorpromazine Hydrochloride-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clopidogrel-β-D-glucuronide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlorzoxazone-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Chlorzoxazone (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Chlorzoxazone-13C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlorzoxazone-13C,15N,d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlorzoxazone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Clomethiazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.35% |
| Zoxazolamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Tabersonine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Tabersonine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.55% |
| Karanjin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Brassinazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Fadrozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Fadrozole hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Imiprothrin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quinestrol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.19% |
| Terbufibrol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.39% |
| Doxylamine-d5 succinate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Doxylamine succinate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| Licopyranocoumarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fomepizole-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fomepizole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Fomepizole hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| 2-Ethylhexyl (E)-3-(4-(methoxy-d3)phenyl)acrylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octinoxate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Resorufin methyl ether |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Metazachlor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Metazachlor-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Pradefovir mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Paroxetine mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denzimol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Praeruptorin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Praeruptorin E |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.18% |
| Fraxinol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.82% |
| Econazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Econazole-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ticlopidine-d4 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ticlopidine-d6 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ticlopidine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Doxepin-d3 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| Doxepin Hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| Oxolamine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paroxetine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Proadifen hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Chlorpromazine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| Methoxyphenamine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Verapamil-d3 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.13% |
| Verapamil hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Memantine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Memantine-d6 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| Moricizine Hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Harmalol hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Potassium 1H-indol-3-yl sulfate-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Quinine sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| Quinidine sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quinidine sulfate dihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clopidogrel hydrogen sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Clopidogrel-d3 hydrogen sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atazanavir sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Clitorin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Sulfaphenazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Sulfaphenazole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Pyributicarb |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Evodol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sorafenib N-oxide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.7% |
| Perilla ketone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Verapamil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Verapamil-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Verapamil EP Impurity C hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| Metyrapone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Hematin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.08% |
| Cholestyramine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bitertanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.70% |
| Bifendate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Isavuconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Isavuconazole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Finrozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Methoxsalen-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Methoxsalen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Apigenin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| Apigenin (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.82% |
| Sudan IV-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Kushenol M |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benzyl alcohol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Alizarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| Rhodionin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| Mosapride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Mosapride citrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Bilberry Extract |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Friedelin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Polygalaxanthone III |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Tolterodine tartrate-d14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ketoconazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Ketoconazole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Ketoconazole-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Ketoconazole carbonyl-13C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Troleandomycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| Abiraterone acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Abiraterone acetate (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Abiraterone acetate-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Polyphyllin H |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Hypericin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.79% |
| m-Tolualdehyde |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| Atazanavir |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.12% |
| Atazanavir-d24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atazanavir-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atazanavir-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Atazanavir-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (3S,5S)-Atorvastatin sodium salt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atovaquone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Atovaquone-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| cis-Atovaquone-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Abiraterone-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.7% |
| Abiraterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| D4-abiraterone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Anastrozole-d12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Anastrozole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Columbamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.38% |
| Fenofibrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Fenofibrate-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Fenofibrate (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Fenofibrate-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fenofibrate-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diosmetin-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bergaptol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| Paroxetine maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| (±)Homoeriodictyol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Galangin-13C3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Galangin (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |
| Galangin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Methysticin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aflatoxin G1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| Gentiopicroside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |